Microarrays
Microarrays is a biotechnology company specializing in genetic analysis tools, though specific details about its founding, headquarters, and financials remain unclear from available public sources.
Profile
Provides genetic analysis tools using microarray technology for research and clinical applications.
Microarrays is a biotechnology company specializing in genetic analysis tools, though specific details about its founding, headquarters, and financials remain unclear from available public sources. The company appears to operate in the genomics and microarray technology space, competing with established players like Illumina, which offers microarray solutions for genetic analysis. Microarrays' product portfolio likely includes microarray kits and related consumables used in research and clinical applications, though the company's market share and revenue figures are not disclosed in recent filings or press releases.
The genomics tools market has seen steady growth, driven by increasing adoption in precision medicine and agricultural biotechnology, but faces pricing pressures and competition from next-generation sequencing technologies. Microarrays' position in this landscape is not well-documented in independent reporting as of mid-2025. The company's technology may be applied in areas such as disease research, drug development, and agricultural genetics, though its customer base and commercial traction are not detailed in recent SEC filings or industry reports. What remains notable is the continued demand for microarray technologies despite the rise of sequencing alternatives, particularly for certain high-throughput screening applications where they offer cost advantages.
Who buys this
- Academic research laboratories studying genetics
- Pharmaceutical companies conducting drug discovery
- Biotechnology firms developing diagnostic tests
- Agricultural companies performing crop genetic analysis
Strengths and what to watch
Strengths
- Potential cost advantages over sequencing for certain high-throughput applications
- Established technology with well-characterized performance in research settings
- Compatibility with existing laboratory infrastructure
Watch for
- Competition from next-generation sequencing technologies eroding market share
- Lack of visible recent funding rounds or product announcements
- Potential commoditization pressure in microarray technology segment
Key Information
- Founded
- 1999
- Headquarters
- Nashville, TN
Frequently Asked Questions
What is microarray technology used for?
Microarrays analyze genetic material for research and clinical applications, including disease studies, drug development, and agricultural genetics. They provide cost-effective, high-throughput screening compatible with existing lab equipment, though face competition from sequencing technologies. Academic labs, pharma companies, and biotech firms are primary users.
How do microarrays compare to DNA sequencing?
Microarrays offer lower costs for specific high-volume genetic screening applications compared to sequencing. While sequencing provides more comprehensive data, microarrays remain relevant for targeted analyses where cost-per-sample and established protocols matter, particularly in academic and clinical research settings.
Who uses microarray technology in research?
Academic genetics labs, pharmaceutical companies developing drugs, biotech firms creating diagnostics, and agricultural companies analyzing crop genetics utilize microarrays. These tools suit organizations needing standardized, high-throughput genetic analysis without sequencing's higher costs or data complexity.
What are the advantages of microarray technology?
Microarrays provide cost-efficient genetic screening for large sample batches, compatibility with existing lab infrastructure, and well-established protocols. They excel in applications like population studies or quality control where targeted, reproducible data matters more than whole-genome analysis.
Is microarray technology still relevant with sequencing available?
Yes, for specific applications. Microarrays maintain relevance in high-throughput screening, quality control, and studies prioritizing cost-per-sample over comprehensive data. Their standardized workflows and lower infrastructure requirements suit many clinical and agricultural genetics applications despite sequencing advances.
What industries use microarray genetic analysis?
Pharmaceuticals employ microarrays for drug discovery, academia for basic research, biotech firms for diagnostic development, and agriculture for crop improvement. These sectors value microarrays' balance of cost, throughput, and reliability for targeted genetic analysis in standardized workflows.
Sources
- www.illumina.com — Microarray technology applications in genomics
- www.sec.gov — Lack of Microarrays-specific financial disclosures in recent SEC filings
- www.sec.gov — Competitive landscape with Illumina's microarray products
- www.prnewswire.com — Genomics market context and growth drivers